MedTrace Logo

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

NCT06971627 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-05-14

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.

Conditions

  • Inflammatory Bowel Disease (IBD)
  • Medication Compliance
  • Quality of Life
  • Telehealth Monitoring

Interventions

BEHAVIORAL

Nurse-led Telehealth Monitoring Program

Participants in the intervention group will be included in a structured telehealth monitoring program led by a nurse for 12 weeks.

OTHER

No intervention

Participants in the control group will only receive standard care. No additional interventions will be implemented during the 12-week period.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Kimya Kılıçaslan, PhD Candidate · Istanbul University - Cerrahpasa Institute of Graudate Studies

  • Zeliha Tulek, PhD, Prof. · Istanbul University - Cerrahpasa, Florence Nightingale Faculty of Nursing

  • Aykut Ferhat Çelik, MD, Prof. · Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-20
Primary Completion
2024-07-20
Completion
2025-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06971627 on ClinicalTrials.gov